Project Grant F31AI183650
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $456,911 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Illinois to research innovative antibiotic combinations for treating hypervirulent Klebsiella pneumoniae (HVKP) infections. The 2-year project, running from July 1, 2025 to June 30, 2027, will investigate how excess capsular polysaccharide production in multidrug-resistant HVKP strains reduces the activity...
- This National Institutes of Health National Heart Lung and Blood Institute project grant of $460,175.84 supports research into the effects of acidosis on pneumonia through December 31, 2021. The award funds a study at the University of South Alabama examining how the carbonic anhydrase IX isoform and cytotoxic amyloid proteins impact pulmonary endothelial cell function during Pseudomonas aeruginosa infection. Specifically, the research will test the hypotheses that CA IX is critical to acid...
- This Project Grant award of $189,146.00 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), supports a 5-year research career development program led by Dr. Glenn J. Rapsinski at the University of Pittsburgh. The project aims to study the evolution and adaptations of the pathogen Pseudomonas aeruginosa in children with tracheostomy tubes, and how these adaptations impact host responses and...
- This $427,625 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to understand the causes of treatment failure for hypervirulent Klebsiella pneumoniae liver abscesses. The research aims to visualize antibiotic distribution and the role of antibiotic-tolerant bacterial cells in this treatment failure, as well as examine the transcriptional profile of the bacteria in...
- This Project Grant award of $249,000 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research (CFDA 93.855) program, is funding research to define the mechanisms by which macrophages restrict the growth of Klebsiella pneumoniae (KP) during bacteremia and sepsis. The central hypothesis is that tissue-resident macrophages provide distinct niches that restrict or permit KP in a manner dependent on bacterial initiation of cell death...
- This $1.23 million Project Grant from the National Institutes of Health's National Institute of Allergy and Infectious Diseases will fund research at Loyola University of Chicago from June 2022 to May 2025 under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant aims to further the university's investigation into how certain species of Lactobacillus bacteria found in the female urinary tract can control colonization of uropathogenic Escherichia coli (UPEC) through...
- This $427,625 Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) with a period of performance from July 1, 2025 to June 30, 2027. The grant supports research at the University of North Carolina at Chapel Hill to elucidate the role of fimbriae (hair-like surface appendages) in Klebsiella pneumoniae-mediated liver abscess formation. The goal is to investigate the specific...
- This $259,461 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), supports research to investigate the mechanisms of resistance and clinical outcomes of non-carbapenemase producing carbapenem-resistant Klebsiella pneumoniae (NCP-KPN) infections. The research, conducted by The Methodist Hospital Research Institute, aims to elucidate the drivers behind the discordance...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $453,750 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for research on Pseudomonas aeruginosa infections and neutrophil swarming behavior. The funding will support a 2-year project to develop an ex vivo model to study how neutrophils coordinate to surround and neutralize large bacterial...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $383,750 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Nebraska Medical Center (UNMC) to discover novel antimicrobial peptides that can effectively eliminate drug-resistant gram-negative bacteria. The project aims to elucidate the structure-activity relationship, toxicity, pharmacokinetics, and in vivo efficacy of a novel antimicrobial peptide called Verine...
INFLUENCE OF ARGININE ON KLEBSIELLA PNEUMONIAE MUCOIDY AND PATHOGENESIS - PROJECT SUMMARY HYPERVIRULENT KLEBSIELLA PNEUMONIAE (HVKP) IS A GROWING GLOBAL THREAT WITHIN COMMUNITY SETTINGS. HVKP CAUSES SEVERE LIVER ABSCESSES THAT CAN SPREAD TO THE EYES AND CENTRAL NERVOUS SYSTEM. ONE DISTINCT FEATURE OF MOST HVKP STRAINS IS THE PRESENCE OF VISUALLY DISTINGUISHABLE MUCOID COLONIES, THAT ADHERE TO LOOPS AND EXHIBIT A MEASURABLE STRETCH FROM AGAR PLATES. THESE COLONIES HAVE LONGER CAPSULAR POLYSACCHARIDE CHAINS, RESULTING IN A MUCOID APPEARANCE AND INCREASED DISEASE SEVERITY. HOWEVER, THE REGULATION OF MUCOIDY BY EXTRACELLULAR SIGNALS AND ITS ADAPTATION TO HUMAN HOSTS IS POORLY UNDERSTOOD. THIS PROPOSAL AIMS TO PROVIDE HIGH-IMPACT TRAINING TO A DOCTORAL STUDENT, IN PART THROUGH MENTORED RESEARCH TO IDENTIFY EXTERNAL NUTRIENT SIGNALS RESPONSIBLE FOR REGULATING MUCOIDY IN K. PNEUMONIAE. INITIAL OBSERVATIONS SHOWED INCREASED MUCOIDY WHEN K. PNEUMONIAE WAS GROWN IN A MINIMAL MEDIUM SUPPLEMENTED WITH CASAMINO ACIDS. IMPORTANTLY, THIS INCREASE IN MUCOIDY WAS INDEPENDENT OF CAPSULE ABUNDANCE, THUS PROMPTING OUR FOCUS ON AMINO ACIDS. SUBSEQUENT EXPERIMENTS ELIMINATING ONE AMINO ACID AT A TIME SUGGESTED THAT ARGININE IS A KEY SIGNAL FOR MUCOIDY VIA EFFECTS ON CAPSULE CHAIN LENGTH. THE CENTRAL HYPOTHESIS OF THE RESEARCH COMPONENT OF THIS TRAINING PROPOSAL IS THAT GENES OR METABOLITES IN ARGININE CATABOLIC PATHWAYS REGULATE MUCOIDY AND CONTRIBUTE TO PATHOGENESIS. TO ADDRESS THIS HYPOTHESIS AND ACHIEVE THE PROPOSAL'S GOALS, WE WILL FIRST IDENTIFY THE ARGININE SIGNALING PATHWAYS THAT ARE ALTERING MUCOIDY. WE WILL EMPLOY ESTABLISHED SEDIMENTATION ASSAYS TO ASSESS MUCOIDY IN VARIOUS ARGININE MUTANTS. WE WILL ALSO DETERMINE THE EFFECTS OF ARGININE ON TRANSCRIPT LEVELS OF MUCOID-RELATED GENES, USING QPCR. FURTHERMORE, WE WILL EVALUATE THE INTRACELLULAR SURVIVAL, ESCAPE ABILITY, AND MUCOIDY OF AN ARGININE IMPORT MUTANT WITHIN CULTURED MACROPHAGES INFECTED BY K. PNEUMONIAE. THIS INVESTIGATION WILL SHED LIGHT ON THE ROLES OF ARGININE AVAILABILITY, AND MUCOIDY IN THE INTRACELLULAR SURVIVAL OF K. PNEUMONIAE WITHIN MACROPHAGES. ADDITIONALLY, USING A MURINE BACTEREMIA MODEL, WE WILL ASSESS DISSEMINATION AND RMPD EXPRESSION IN AN ARGININE IMPORT MUTANT TO EVALUATE THE CONTRIBUTION OF HOST ARGININE IN HVKP DISSEMINATION. COLLECTIVELY, THESE DATA WILL IDENTIFY HOW ARGININE REGULATES MUCOIDY AND ALTERS THE INTRACELLULAR FITNESS OF K. PNEUMONIAE. THESE FINDINGS LAY THE GROUNDWORK FOR FUTURE RESEARCH ENDEAVORS INTO THE PATHOGENICITY OF K. PNEUMONIAE IN DISEASE STATES THAT CAUSE FLUCTUATIONS IN ARGININE LEVELS, ENHANCING OUR ABILITY TO COMBAT INFECTIONS CAUSED BY HYPERVIRULENT STRAINS. THIS RESEARCH WILL BE CARRIED OUT IN THE CONTEXT OF A RIGOROUS AND ACTIVELY MENTORED TRAINING PROGRAM.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $39.1k | 7/9/25 |